Contents

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Volume 4 - Number 3

Preface [Hot Topic: Endocrinology Meets Molecular Oncology: Beyond Radioactive Iodine (Guest Editor: Robert C. Smallridge)]

, 4(3): ii

R. C. Smallridge


DOI: 10.2174/1568008043339848




The Sodium-Iodide Symporter

, 4(3): 167 - 174

C. H. Baker and J. C. Morris


DOI: 10.2174/1568005310404030167




Redifferentiation Therapy in Advanced Thyroid Cancer

, 4(3): 175 - 180

Bryan R. Haugen


DOI: 10.2174/1568005310404030175




AKT: A Potential Target for Thyroid Cancer Therapy

, 4(3): 181 - 185

Faiza Kada, Motoyasu Saji and Matthew D. Ringel


DOI: 10.2174/1568005310404030181




Molecular Elements of Apoptosis-Regulating Pathways in Follicular Thyroid Cells: Mining for Novel Therapeutic Targets in the Treatment of Thyroid Carcinoma

, 4(3): 187 - 198

N. J. Sarlis and L. Gourgiotis


DOI: 10.2174/1568005310404030187




Targeting the ERK Pathway: Novel Therapeutics for Thyroid Cancer

, 4(3): 199 - 220

Sandra F. Williams and Robert C. Smallridge


DOI: 10.2174/1568005310404030199




The PAX8 / PPARγ Fusion Oncogene as a Potential Therapeutic Target in Follicular Thyroid Carcinoma

, 4(3): 221 - 234

Bryan McIver, Stefan K.G. Grebe and Norman L. Eberhardt


DOI: 10.2174/1568005310404030221




Viral Mediated Gene Therapy for the Management of Metastatic Thyroid Carcinoma

, 4(3): 235 - 244

Leslie J. DeGroot and Rusheng Zhang


DOI: 10.2174/1568005310404030235




Dendritic Cell-Based Immunotherapy in Thyroid Malignancies

, 4(3): 245 - 251

Matthias Schott, Werner A. Scherbaum and Jochen Seissler


DOI: 10.2174/1568005310404030245




Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer

, 4(3): 253 - 256

M. A. Zeiger and A. K. Meeker


DOI: 10.2174/1568005310404030253




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science